FAP and pancreatic neoplasm: In the study by Tadashi Watabe et al., dPET was employed to evaluate 64Cu and 225Ac to label mice with human pancreatic cancer xenografts using a FAP inhibitor (FAPI) and found that it significantly inhibited tumor growth (76), while Yuwei Liu et al.